NASDAQ:ALRN
Delisted

Aileron Therapeutics Stock Predictions

etoro logo Buy ALRN
*Your capital is at risk
$2.11
+0 (+0%)
At Close: Apr 09, 2025
Currently predicting for Mon, 8 Jun 2026

ALRN Prediction Chart

ALRN Predictions History

Latest community submissions for ALRN.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Oct 27, 2020 $1.62 -93.67% $1.28 X 73.44% 0
iHustle84 iHustle84 Pro
Oct 27, 2020 $1.00 -96.09% $1.28 V 78.13% 1
Scott Browder Scott Browder @ScottBrowder.176245
Oct 27, 2020 $1.32 -94.84% $1.28 V 96.88% 1
JS JS Pro
Oct 26, 2020 $1.88 -93.31% $1.41 V 66.19% 1
iHustle84 iHustle84 Pro
Oct 26, 2020 $1.49 -94.70% $1.41 V 93.95% 1
Krystal Dunlap Krystal Dunlap @KrystalDunlap.176362
Oct 26, 2020 Bullish $1.41 X 0
JS JS Pro
Oct 14, 2020 $1.81 -95.76% $2.14 V 84.78% 0
Jade Mikalauskas Jade Mikalauskas @JadeMikalauskas.168410
Oct 14, 2020 Bearish $2.14 V 0
JS JS Pro
Oct 13, 2020 $1.71 -95.50% $1.90 X 90.00% 1
JS JS Pro
Jul 20, 2020 $1.09 -94.95% $1.08 X 99.07% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALRN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AILERON THERAPEUTICS INC
Aileron Therapeutics
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE